Tag: pharmaceuticals
-
First Therapies Selected for Multi-Drug ALS Trial
A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, beginning with the first three therapies.
-
Start-Up Targets Extra DNA in Cancer, Raises $46.4M
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes.
-
Gel, Crispr Help Defeat Cancer Drug Obstacles
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells.
-
Migraine Drug Developer Raises $82.5M in IPO
A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock.
-
Hydrogel Shown Safe to Repair Heart Damage
Results of a small-scale clinical trial show an experimental treatment using an injectable gel to repair damage from a heart attack is safe for patients.
-
Gene-Editing Biotech Gains $34M in Early Funds
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles.
-
Experimental Drug Shown to Prevent Memory Loss
A drug candidate designed to compensate for damage to brain cells from toxic proteins prevented nerve cell damage and memory loss in lab mice.
-
Response by Patients Shown to Precision Lung Cancer Drug
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition.
-
Sumitomo Dainippon, Biotechs in $3B Acquisition Deal
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group.
-
Spin-Off Licensing Athletic Microbiome Technology
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics.